Almac launches mobile website in response to large mobile user base
Embedded mobile icon means website can be accessed on the move in just one click
Almac has announced the launch of a mobile optimised version of its website, enabling biotech and pharma clients and prospective customers to access Almac’s content whilst out of the office with only a mobile to hand. The new mobile ready site (designed to work with all mobile operating systems including Android and Apple) contains shortened summaries of all the sections of Almac’s full website broken-down into 6 tabs – ‘Services’, ‘News’, ‘Events’, ‘Locations’, ‘Contact Us’, and ‘Vacancies’.
The new website was created in response to client demands; due to an ever growing number of visitors accessing the main site via mobile devices. The mobile ready site enables users to store an Almac icon on their phone’s screen providing rapid access in just one click, enhanced resolution for all screens sizes, and a search facility enabling visitors to access any content from the full site.
“At Almac we are always looking to help clients with any requirements they have and by launching this new mobile website we are providing even greater accessibility for the significant number of people that view our services and locations through mobile devices. We are one of the first CDMO companies to invest in online technologies to respond to this growing need, providing up to date information on our global portfolio helping to facilitate real time decision making wherever you are.” said Philip Diamond, VP Corporate Market ;Development at Almac.
The new site can be visited on the following address: http://m.almacgroup.com/
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
